Anne Julie Tybjerg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne Julie Tybjerg has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Klaus Kaae Andersen
Danish Cancer Society Research Center, Copenhagen, Denmark 1
4 shared publications- Tom Skyhøj Olsen
Dept. of Neurology Bispebjerg University Hospital, Copenhagen, Denmark
4 shared publications Alejandro Daniel Babore
Department of Neurology, Bispebjerg University Hospital, Copenhagen, Denmark 2
3 shared publications- Klaus Kaae Andersen
Omicron ApS, Copenhagen, Denmark
2 shared publications - Rebecca Beatrix Clarke
Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
2 shared publications - Berit Andersen
University Research Clinic for Cancer Screening (UNICCA), Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
1 shared publication
Latest Publications
- Open Access
- 14 November 2020
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 31 (2) , 340-346
The influence of marital status and partner concordance on participation in colorectal cancer screening
Background: Colorectal cancer screening program using a fecal immunochemical test aims to reduce morbidity and mortality through early detection. Although screening participation is free-of-charge, almost 40% of the invited individuals choose not to participate. To bring new insight into how non-participation can be identified and targeted, we examined the association between marital status and screening participation; with a focus on partner concordance in participation and sex differences. Methods: This nationwide cross-sectional study included all Danish citizens aged 50–74 years, who were invited to colorectal cancer screening between 2014 and 2017. Logistic regression analysis was used to estimate odds ratio (OR) of participation while adjusting for sociodemographic variables. Results: A total of 1 909 662 individuals were included in the analysis of which 62.7% participated in the screening program. Participation was highest among women. Stratified by marital status, screening participation was markedly lower in widowed (61.5%), divorced (54.8%) and single (47.3%), while participation reached 68.4% in married individuals. This corresponded to ORs of 0.59 (95% CI 0.58–0.59) for widowed, 0.56 (95% CI 0.55–0.56) for divorced and 0.47 (95% CI 0.47–0.48) for single, compared to married individuals. Individuals married to a participating partner were five times more likely to participate than married individuals with a non-participating partner, regardless of gender. Conclusions: Marital status was strongly associated with participation in colorectal cancer screening, and participation was even higher in married individuals with a participating partner. Future efforts to increase participation in colorectal cancer screening could potentially benefit from considering the role of partner concordance.
- 14 November 2020
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 31 (2) , 340-346
Open AccessThe influence of marital status and partner concordance on participation in colorectal cancer screening
Background: Colorectal cancer screening program using a fecal immunochemical test aims to reduce morbidity and mortality through early detection. Although screening participation is free-of-charge, almost 40% of the invited individuals choose not to participate. To bring new insight into how non-participation can be identified and targeted, we examined the association between marital status and screening participation; with a focus on partner concordance in participation and sex differences. Methods: This nationwide cross-sectional study included all Danish citizens aged 50–74 years, who were invited to colorectal cancer screening between 2014 and 2017. Logistic regression analysis was used to estimate odds ratio (OR) of participation while adjusting for sociodemographic variables. Results: A total of 1 909 662 individuals were included in the analysis of which 62.7% participated in the screening program. Participation was highest among women. Stratified by marital status, screening participation was markedly lower in widowed (61.5%), divorced (54.8%) and single (47.3%), while participation reached 68.4% in married individuals. This corresponded to ORs of 0.59 (95% CI 0.58–0.59) for widowed, 0.56 (95% CI 0.55–0.56) for divorced and 0.47 (95% CI 0.47–0.48) for single, compared to married individuals. Individuals married to a participating partner were five times more likely to participate than married individuals with a non-participating partner, regardless of gender. Conclusions: Marital status was strongly associated with participation in colorectal cancer screening, and participation was even higher in married individuals with a participating partner. Future efforts to increase participation in colorectal cancer screening could potentially benefit from considering the role of partner concordance.
- 1 September 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (9) , 105023
Occult lung cancer manifesting within the first year after stroke
- 1 September 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (9) , 105023
Occult lung cancer manifesting within the first year after stroke
- Open Access
- 1 September 2020
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 5 (3) , 237-244
Occult primary brain cancers manifesting in the aftermath of ischaemic and haemorrhagic stroke
Introduction: Symptoms of occult brain cancer may mimic stroke. Misdiagnosis may lead to improper treatment and delayed diagnosis. We characterised strokes associated with occult primary brain cancer and determined risk that ischaemic and haemorrhagic strokes are associated with occult primary brain cancer. Patients and methods: All patients with incident stroke in Denmark 2003–2015 were identified through the Danish Stroke Registry (n = 85,893) and matched 1:10 on age and sex to the Danish background population without a stroke history (n = 858,740). This cohort was linked to the Danish Cancer Registry and prevalence of occult primary brain cancer defined as the event of previously unknown primary brain cancer during a one-year follow-up was estimated. We used Cox regression models to study risk of occult primary brain cancer in comparison to the background population. Results: Of 77,484 patients with ischaemic strokes, 39 (1 in 2000) were associated with primary brain cancer; of 8409 with haemorrhagic strokes, it was 126 (1 in 66). In the background cohort, 205 (1 in 4000) had occult primary brain cancer. The multivariate stroke risk factor analysis showed that patients with occult primary brain cancer differed significantly from those without occult primary brain cancer indicating they might have stroke mimics rather than true strokes. Discussion and conclusions: Strokes associated with occult primary brain cancer tend to be stroke mimics rather than true strokes. Primary brain cancer is rare in patients with ischaemic stroke (1 in 2000); risk that misdiagnosis results in maltreatment is, therefore, very low. Occult primary brain cancers are mainly found among patients with haemorrhagic stroke; they are not uncommon (1 in 66) and should always be kept in mind.
- 1 September 2020
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 5 (3) , 237-244
Open AccessOccult primary brain cancers manifesting in the aftermath of ischaemic and haemorrhagic stroke
Introduction: Symptoms of occult brain cancer may mimic stroke. Misdiagnosis may lead to improper treatment and delayed diagnosis. We characterised strokes associated with occult primary brain cancer and determined risk that ischaemic and haemorrhagic strokes are associated with occult primary brain cancer. Patients and methods: All patients with incident stroke in Denmark 2003–2015 were identified through the Danish Stroke Registry (n = 85,893) and matched 1:10 on age and sex to the Danish background population without a stroke history (n = 858,740). This cohort was linked to the Danish Cancer Registry and prevalence of occult primary brain cancer defined as the event of previously unknown primary brain cancer during a one-year follow-up was estimated. We used Cox regression models to study risk of occult primary brain cancer in comparison to the background population. Results: Of 77,484 patients with ischaemic strokes, 39 (1 in 2000) were associated with primary brain cancer; of 8409 with haemorrhagic strokes, it was 126 (1 in 66). In the background cohort, 205 (1 in 4000) had occult primary brain cancer. The multivariate stroke risk factor analysis showed that patients with occult primary brain cancer differed significantly from those without occult primary brain cancer indicating they might have stroke mimics rather than true strokes. Discussion and conclusions: Strokes associated with occult primary brain cancer tend to be stroke mimics rather than true strokes. Primary brain cancer is rare in patients with ischaemic stroke (1 in 2000); risk that misdiagnosis results in maltreatment is, therefore, very low. Occult primary brain cancers are mainly found among patients with haemorrhagic stroke; they are not uncommon (1 in 66) and should always be kept in mind.
- 19 June 2020
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 142 (5) , 486-492
Types of occult cancer in stroke and the relation to smoking
Objectives Stroke is associated with a higher risk of occult cancer. We studied the types of occult cancer most often associated with stroke. Materials and Methods All patients with incident stroke in Denmark 2003‐2015 were identified through the Danish Stroke Registry (n = 85 893) and matched 1:10 on age and sex to the Danish background population without history of stroke (n = 858 740). Linking data to the Danish Cancer Registry, we determined the prevalence of occult cancer in stroke defined as the event of previously unknown cancer during a one‐year follow‐up in the stroke and the background population. We stratified cancers into the 15 most common cancers and into cancers related to and not related to smoking. Results Prevalence (per 1000 person‐years; stroke/background population) of smoking‐related occult cancers (lung, colon, bladder rectum, pancreas, kidney, stomach, and head and neck) was 13.3/8.1 (P < .01) and of cancers not related to smoking (prostate, breast, melanoma, non‐Hodgkin lymphoma, ovary, endometrial) it was 6.6/6.2 (P > .05). Among men with stroke prostate (5.8), lung (5.7), and colon cancers (2.9) were most frequent; among women, it was lung (4.7), breast(3.5), and colon cancer(2.8). Among men in the background population, prostate(5.4), lung (3.0), and colon cancers (2.1) were most frequent. Among women, it was breast (3.7), lung(2.1), and colon cancers (1.9). Conclusion Stroke patients' increased risk of occult cancer was predominantly for smoking‐related cancers while there was no higher risk for the most frequent cancers unrelated to smoking, that is, prostate and breast cancers. Lung cancer is the dominant type of occult cancer in stroke.
- 19 June 2020
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 142 (5) , 486-492
Types of occult cancer in stroke and the relation to smoking
Objectives Stroke is associated with a higher risk of occult cancer. We studied the types of occult cancer most often associated with stroke. Materials and Methods All patients with incident stroke in Denmark 2003‐2015 were identified through the Danish Stroke Registry (n = 85 893) and matched 1:10 on age and sex to the Danish background population without history of stroke (n = 858 740). Linking data to the Danish Cancer Registry, we determined the prevalence of occult cancer in stroke defined as the event of previously unknown cancer during a one‐year follow‐up in the stroke and the background population. We stratified cancers into the 15 most common cancers and into cancers related to and not related to smoking. Results Prevalence (per 1000 person‐years; stroke/background population) of smoking‐related occult cancers (lung, colon, bladder rectum, pancreas, kidney, stomach, and head and neck) was 13.3/8.1 (P < .01) and of cancers not related to smoking (prostate, breast, melanoma, non‐Hodgkin lymphoma, ovary, endometrial) it was 6.6/6.2 (P > .05). Among men with stroke prostate (5.8), lung (5.7), and colon cancers (2.9) were most frequent; among women, it was lung (4.7), breast(3.5), and colon cancer(2.8). Among men in the background population, prostate(5.4), lung (3.0), and colon cancers (2.1) were most frequent. Among women, it was breast (3.7), lung(2.1), and colon cancers (1.9). Conclusion Stroke patients' increased risk of occult cancer was predominantly for smoking‐related cancers while there was no higher risk for the most frequent cancers unrelated to smoking, that is, prostate and breast cancers. Lung cancer is the dominant type of occult cancer in stroke.
- 14 April 2020
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 59 (8) , 1002-1006
Use of primary health care and participation in colorectal cancer screening – a Danish national register-based study
(2020). Use of primary health care and participation in colorectal cancer screening – a Danish national register-based study. Acta Oncologica. Ahead of Print.
- 14 April 2020
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 59 (8) , 1002-1006
Use of primary health care and participation in colorectal cancer screening – a Danish national register-based study
(2020). Use of primary health care and participation in colorectal cancer screening – a Danish national register-based study. Acta Oncologica. Ahead of Print.
- 7 November 2019
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 141 (3) , 204-211
Prevalence and risk of occult cancer in stroke
Objectives Cancer is associated with higher risk of stroke. Whether this translates into higher risk of cancer in stroke of an extent calling for cancer screening in stroke is unclear. We investigated prevalence and risk of occult cancer in stroke compared to the background population without history of stroke. Materials & Methods All patients >40 years of age with incident stroke in Denmark 2003‐2015 were identified through the Danish Stroke Registry (n=85,893) and matched 1:10 on age and sex to the Danish background population without history of stroke (n=858,740). Linking data to the Danish Cancer Registry we determined prevalence of occult cancer in stroke defined as the event of previously unknown cancer during a one‐year follow‐up in the stroke and in the background population. Cox regression models were used to study risk in comparison to the background population. Results Prevalence (per 1,000) of occult cancer in the stroke/background cohorts was 25.0/15.8 in women and 29.8/20.4 in men. Prevalence was dependent on age and sex. Highest among stroke patients aged 70‐80 years (35.6 in women, 42.4 in men); lowest in patients aged 40‐50 years (8.3 in women, 6.8 in men). Stroke was associated with an overall 54% higher risk of occult cancer but risk increased significantly with smoking, Hazard Ratio (HR) 1.47, age HR 1.27 per10 years, male sex HR 1.25 and diabetes HR 1.25. Conclusions Prevalence and risk of occult cancer in stroke is considerable and calls for attention when designing the stroke investigation program.
- 7 November 2019
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 141 (3) , 204-211
Prevalence and risk of occult cancer in stroke
Objectives Cancer is associated with higher risk of stroke. Whether this translates into higher risk of cancer in stroke of an extent calling for cancer screening in stroke is unclear. We investigated prevalence and risk of occult cancer in stroke compared to the background population without history of stroke. Materials & Methods All patients >40 years of age with incident stroke in Denmark 2003‐2015 were identified through the Danish Stroke Registry (n=85,893) and matched 1:10 on age and sex to the Danish background population without history of stroke (n=858,740). Linking data to the Danish Cancer Registry we determined prevalence of occult cancer in stroke defined as the event of previously unknown cancer during a one‐year follow‐up in the stroke and in the background population. Cox regression models were used to study risk in comparison to the background population. Results Prevalence (per 1,000) of occult cancer in the stroke/background cohorts was 25.0/15.8 in women and 29.8/20.4 in men. Prevalence was dependent on age and sex. Highest among stroke patients aged 70‐80 years (35.6 in women, 42.4 in men); lowest in patients aged 40‐50 years (8.3 in women, 6.8 in men). Stroke was associated with an overall 54% higher risk of occult cancer but risk increased significantly with smoking, Hazard Ratio (HR) 1.47, age HR 1.27 per10 years, male sex HR 1.25 and diabetes HR 1.25. Conclusions Prevalence and risk of occult cancer in stroke is considerable and calls for attention when designing the stroke investigation program.
- Open Access
- 1 November 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 10, 1649-1655
Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
Background: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. Objective: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. Methods: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. Results: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). Conclusion: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies.
- 1 November 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 10, 1649-1655
Open AccessColonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
Background: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. Objective: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. Methods: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. Results: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). Conclusion: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies.